Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale Director sold 25,000 shares at an average $82.80 ($2,070,050)
  2. 4 Open-market sale SVP & Chief Financial Officer sold 90,000 shares at an average $84.05 ($7,564,200)
  3. 4 Open-market sale President & CEO sold 130,000 shares at an average $84.05 ($10,926,066)
  4. 4 Exercise or conversion Director acquired 30,000 shares (option exercise)
  5. 4 Open-market sale SVP & Chief Accounting Officer sold 13,881 shares at $101.46 ($1,408,366)
  6. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 502 shares at $105.67 ($53,046)
  7. 4 Open-market sale Director sold 30,000 shares at $101.74 ($3,052,200)
  8. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 29,498 shares at an average $102.81 ($3,032,765)
  9. 4 Open-market sale Director sold 30,000 shares at $92.22 ($2,766,600)
  10. 4 Open-market sale SVP & Chief Scientific Officer sold 160,000 shares at an average $93.06 ($14,890,180)
  11. 4 Open-market sale Director sold 25,000 shares at an average $92.14 ($2,303,600)
  12. 4 Open-market sale Director sold 40,000 shares at an average $97.60 ($3,903,914)
  13. 4 Open-market sale SVP & Chief Operating Officer sold 220,144 shares at an average $99.27 ($21,854,265)
  14. 4 Open-market sale SVP & Chief Accounting Officer sold 2,545 shares at $82.94 ($211,082)
  15. 4 Open-market sale President & CEO sold 12,788 shares at $82.94 ($1,060,637)
  16. 4 Open-market sale SVP & Chief Operating Officer sold 4,879 shares at $82.94 ($404,664)
  17. 4 Open-market sale SVP & Chief Financial Officer sold 3,477 shares at $82.94 ($288,382)
  18. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,875 shares at $82.94 ($238,453)
  19. 4 Open-market sale SVP & Chief Scientific Officer sold 2,426 shares at $82.94 ($201,212)
  20. 4 Exercise or conversion SVP & Chief Operating Officer acquired 120,000 shares (option exercise)

Page 18 of 49 · 970 filings